Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?

J Am Coll Cardiol. 2012 Sep 11;60(11):978-80. doi: 10.1016/j.jacc.2012.06.014. Epub 2012 Aug 22.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Aortic Valve / surgery*
  • Aspirin / therapeutic use*
  • Bioprosthesis / adverse effects*
  • Female
  • Heart Valve Prosthesis / adverse effects*
  • Humans
  • Male
  • Thromboembolism / prevention & control*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin
  • Aspirin